DAPT study
ClinicalTrials.gov NCT03218787
Research payments
$2,799,401
Through program year 2019, $2,799,401 in research payments was reported against DAPT study, across 470 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- NCT03218787
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $2,799,401 | 470 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Martin Burke Minneapolis, MN Named on 15 payments
- Daniel Lee Ann Arbor, MI Named on 14 payments
- Aravinda Nanjundappa Bluefield, WV Named on 12 payments
- Daniel Spoon Missoula, MT Named on 12 payments
- James Choi Dallas, TX Named on 9 payments
- William Felten Pigeon, MI Named on 9 payments
- Kevin Clayton Traverse City, MI Named on 9 payments
- Ameer Kabour Toledo, OH Named on 8 payments
- William Bachinsky Wormleysburg, PA Named on 7 payments
- Tomasz Stys Sioux Falls, SD Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.